MARC2 antibody (C-Term)

Catalog No. ABIN2842422

Product Details anti-MARC2 Antibody

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Binding Specificity: AA 270-300, C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MARC2 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This MOSC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 270-300 amino acids from the C-terminal region of human MOSC2.

Clone: RB22590

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Expiry Date: 6 months

Target Details for MARC2

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Alternative Name: MOSC2 (MARC2 Products)

Synonyms: MOSC2 antibody, RP11-270A6.1 antibody, 2810484M10Rik antibody, Mosc2 antibody, mARC1 antibody, Mg87 antibody, mARC2 antibody, mitochondrial amidoxime reducing component 1 antibody, mitochondrial amidoxime reducing component 2 antibody, MARC1 antibody, MARC2 antibody, Marc2 antibody

Background: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.

Molecular Weight: 38023

Gene ID: 54996

NCBI Accession: NP_060368

UniProt: Q969Z3